The Ig heavy chain variable region's mutation status is prognostic with unmutated forms (U-CLL) showing enhanced B cell receptor (BCR)-signaling and being prognostically adverse in patients treated with chemotherapy [6–8]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.